BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20062079)

  • 41. TEF, an antiapoptotic bZIP transcription factor related to the oncogenic E2A-HLF chimera, inhibits cell growth by down-regulating expression of the common beta chain of cytokine receptors.
    Inukai T; Inaba T; Dang J; Kuribara R; Ozawa K; Miyajima A; Wu W; Look AT; Arinobu Y; Iwasaki H; Akashi K; Kagami K; Goi K; Sugita K; Nakazawa S
    Blood; 2005 Jun; 105(11):4437-44. PubMed ID: 15665112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia.
    Liang DC; Shih LY; Yang CP; Hung IJ; Chen SH; Jaing TH; Liu HC; Chang WH
    Med Pediatr Oncol; 2002 Jul; 39(1):12-7. PubMed ID: 12116073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
    Feldman BJ; Reid TR; Cleary ML
    Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proviral activation of the tumor suppressor E2a contributes to T cell lymphomagenesis in EmuMyc transgenic mice.
    Mikkers H; Allen J; Berns A
    Oncogene; 2002 Sep; 21(43):6559-66. PubMed ID: 12242653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Promoter analysis of TFPT (FB1), a molecular partner of TCF3 (E2A) in childhood acute lymphoblastic leukemia.
    Brambillasca F; Mosna G; Ballabio E; Biondi A; Boulukos KE; Privitera E
    Biochem Biophys Res Commun; 2001 Nov; 288(5):1250-7. PubMed ID: 11700047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
    Sun L; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Mao C; Vassilev A; Reaman GH; Uckun FM
    Clin Cancer Res; 1999 Aug; 5(8):2112-20. PubMed ID: 10473095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of the DBP promoter by PAR proteins and in leukemic cells bearing an E2A/HLF translocation.
    Newcombe K; Glassco T; Mueller C
    Biochem Biophys Res Commun; 1998 Apr; 245(2):633-9. PubMed ID: 9571207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.
    Kamps MP; Wright DD
    Oncogene; 1994 Nov; 9(11):3159-66. PubMed ID: 7936638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
    Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
    Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.
    Huang Y; Mouttet B; Warnatz HJ; Risch T; Rietmann F; Frommelt F; Ngo QA; Dobay MP; Marovca B; Jenni S; Tsai YC; Matzk S; Amstislavskiy V; Schrappe M; Stanulla M; Gstaiger M; Bornhauser B; Yaspo ML; Bourquin JP
    Cancer Cell; 2019 Dec; 36(6):630-644.e9. PubMed ID: 31735627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.
    Smith KS; Jacobs Y; Chang CP; Cleary ML
    Oncogene; 1997 Jun; 14(24):2917-26. PubMed ID: 9205098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells.
    Bond HM; Mesuraca M; Amodio N; Mega T; Agosti V; Fanello D; Pelaggi D; Bullinger L; Grieco M; Moore MA; Venuta S; Morrone G
    Int J Biochem Cell Biol; 2008; 40(5):848-54. PubMed ID: 17543573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
    Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
    Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two candidate downstream target genes for E2A-HLF.
    Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
    Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19.
    Inukai T; Hirose K; Inaba T; Kurosawa H; Hama A; Inada H; Chin M; Nagatoshi Y; Ohtsuka Y; Oda M; Goto H; Endo M; Morimoto A; Imaizumi M; Kawamura N; Miyajima Y; Ohtake M; Miyaji R; Saito M; Tawa A; Yanai F; Goi K; Nakazawa S; Sugita K
    Leukemia; 2007 Feb; 21(2):288-96. PubMed ID: 17183364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein.
    Inukai T; Inoue A; Kurosawa H; Goi K; Shinjyo T; Ozawa K; Mao M; Inaba T; Look AT
    Mol Cell; 1999 Sep; 4(3):343-52. PubMed ID: 10518215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcriptional regulation of the proto-oncogene Zfp521 by SPI1 (PU.1) and HOXC13.
    Yu M; Al-Dallal S; Al-Haj L; Panjwani S; McCartney AS; Edwards SM; Manjunath P; Walker C; Awgulewitsch A; Hentges KE
    Genesis; 2016 Oct; 54(10):519-533. PubMed ID: 27506447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.
    Duque-Afonso J; Feng J; Scherer F; Lin CH; Wong SH; Wang Z; Iwasaki M; Cleary ML
    J Clin Invest; 2015 Sep; 125(9):3667-80. PubMed ID: 26301816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
    Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
    Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.